Bupropion Tablet, Extended Release
Product Images NDC 65841-836

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion (NDC 65841-836). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

577eda07 Fd4e 494e A769 5338ba679892 02

This is a description of a medication called "BuPROPion Hydrochloride Extended-Release Tablets" that contains 300mg of the active ingredient. The medication is in tablet form and is designed for once-daily use. The tablets are manufactured by the company Zydus and bear the NDC code 65841-780-05. Patients are warned not to take this medication out of the reach of children.*

FDA Label Image

577eda07 Fd4e 494e A769 5338ba679892 03

This is a description of a medication called "buPROPion oo cmeroPon oo 5P Hydrochloride" in an extended-release form. Its usual dosage is one tablet per day. There is a warning not to use it with other medications that contain bupropion hydrochloride, including Zyban®. The medication comes in a container that is resistant to moisture and should be kept out of reach of children. The manufacturer of this medication is Zydus Healthcare, located in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.